Bhatia, N. .; Kantor, J. .; Green, L. .; Weiss, J. .; Willson, C.; Cutler, S.; Rieger, J.; Glover, D. K.; Rumney, P.; Goldenberg, G. Results from Part 1 Safety Run-in Period of a 2-Part, Phase 2, Multicenter, Open-Label, Proof-of-Concept Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VP-315 in Subjects With Basal Cell Carcinoma. J of Skin 2023, 7, s260.